Autologous Stem Cell Transplantation for Aggressive Lymphomas

The role of high-dose therapy (HDT) followed by autologous stem cell transplantation (ASCT) in the treatment armamentarium of aggressive B- and T-cell non-Hodgkin lymphoma (NHL) is still a matter of debate. In the pre-Rituximab era, the PARMA study demonstrated the superiority of HDT/ASCT over conve...

Descripción completa

Detalles Bibliográficos
Autores principales: Visani, Giuseppe, Picardi, Paola, Tosi, Patrizia, Gonella, Roberta, Loscocco, Federica, Ricciardi, Teresa, Malerba, Lara, Guiducci, Barbara, Tomassetti, Simona, Barulli, Sara, Isidori, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2012
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507533/
https://www.ncbi.nlm.nih.gov/pubmed/23205263
http://dx.doi.org/10.4084/MJHID.2012.075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507533/
https://www.ncbi.nlm.nih.gov/pubmed/23205263
http://dx.doi.org/10.4084/MJHID.2012.075

Ejemplares similares